Veeva Says DQS System Has Cleaned Data for More Than 1 Million Clinical Trial Subjects
MT Newswires Live
Oct 06
Veeva Systems (VEEV) said Tuesday its DQS platform has aggregated and cleaned data for more than 1 million subjects in over 1,000 clinical studies, helping to accelerate data analysis.
The system has automated more than 500,000 data checks, saving thousands of hours of manual reconciliation work for trial sites and sponsors, the company said.
Veeva said DQS uses AI to classify study data and automate data-management tasks, helping clinical teams identify important changes and potential issues in trials.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.